Pharmaceutical vials are the most widely used product type in the parenteral packaging market, valued for their versatility, broad acceptance, and ability to preserve the integrity of various injectable drugs. Vials account for the largest share as they are extensively used for injectable drugs, vaccines, and biologics [citation:MRFR]. They have established themselves as the dominant product type due to their broad usage in storing various injectable solutions [citation:MRFR]. Vials are particularly favored for their ability to preserve drug integrity and facilitate aseptic filling processes [citation:MRFR].

Vials are available in various sizes and materials, with glass being the traditional and still dominant choice due to its inert nature and protective qualities [citation:MRFR]. Glass vials ensure the stability of enclosed medications, particularly for products sensitive to light and oxygen, providing robust protection [citation:MRFR]. However, the market is also seeing the emergence of plastic vials, made from materials like cyclic olefin polymer (COP) and cyclic olefin copolymer (COC), which offer advantages in terms of weight and breakage resistance. The development of new materials, such as COP vials, is enhancing the stability and safety of sensitive biologic drugs requiring parenteral administration [citation:MRFR]. The increasing demand for biologics and biosimilars is a key driver for the vial market, as these products often require specialized packaging to ensure stability and safety. The market for vials is expected to continue its growth, supported by the expanding pharmaceutical industry and the increasing number of injectable drugs in development. By 2035, vials will continue to be a fundamental component of the parenteral packaging market, providing a reliable and versatile solution for drug containment.

Get More Insights: Parenteral Packaging Market Report

• pre press packaging market
• shielding gas for welding market
• vinyl cyclohexane market